RecruitingNCT04772768

Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Patients With Prior Coronary Artery Bypass Graft Surgery Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease


Sponsor

Amsterdam UMC, location VUmc

Enrollment

500 participants

Start Date

Aug 23, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multi-center, observational cohort study including patients with prior coronary artery bypass grafting (CABG) and ≥1 saphenous vein grafts (SVG) presenting with recurrent ischemic symptoms. Objective: to investigate the clinical outcomes in patients with prior CABG evaluated for bypass graft failure and progression of native coronary artery disease (CAD). Follow-up will be collected through national registry databases, electronic medical patient records and standardized telephonic assessment at 3 and 5 years follow-up.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria3

  • Prior coronary artery bypass grafting
  • One or more saphenous vein grafts
  • Recurrent angina symptoms

Exclusion Criteria5

  • \<18 years of age
  • ≥ 90 years of age
  • Cardiogenic shock
  • Pregnancy
  • Failure to provide informed consent

Locations(1)

Amsterdam University Medical Centers, Department of Cardiology

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04772768


Related Trials